Hermosilla, Zaiton S.

HRN: 25-20-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2024
CEFUROXIME 1.5GM (VIAL)
06/04/2024
06/04/2024
IV
1.5 And Prior To Or
Once Prior To Or
Surgical Prophylaxis
Waiting Final Action 
06/04/2024
CEFUROXIME 1.5GM (VIAL)
06/04/2024
06/05/2024
IV
1.5g
Q8
CS
Waiting Final Action 
06/05/2024
CEFUROXIME 500MG (TAB)
06/05/2024
06/11/2024
PO
500mg
BID
CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: